218 related articles for article (PubMed ID: 19856826)
1. The first-trimester screen in clinical practice.
Knutsen-Larson S; Flanagan JD; Van Eerden P; Stein QP
S D Med; 2009 Oct; 62(10):389, 392-3. PubMed ID: 19856826
[TBL] [Abstract][Full Text] [Related]
2. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
3. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
[TBL] [Abstract][Full Text] [Related]
4. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
[TBL] [Abstract][Full Text] [Related]
5. A new approach to calculating the risk of chromosomal abnormalities with first-trimester screening data.
Merz E; Thode C; Alkier A; Eiben B; Hackelöer BJ; Hansmann M; Huesgen G; Kozlowski P; Pruggmaier M; Wellek S
Ultraschall Med; 2008 Dec; 29(6):639-45. PubMed ID: 19085755
[TBL] [Abstract][Full Text] [Related]
6. [Effect of maternal smoking on concentrations of the pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of chorionic gonadotropin (beta hCG) in the first trimester of pregnancy].
Gajewska J; Ceran A; Chełchowska M; Borowski D; Ambroszkiewicz J; Jaczyńska R; Zwoliński J; Laskowska-Klita T
Przegl Lek; 2008; 65(10):479-82. PubMed ID: 19189527
[TBL] [Abstract][Full Text] [Related]
7. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
8. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
[TBL] [Abstract][Full Text] [Related]
9. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
Sharda S; Phadke SR
J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
[TBL] [Abstract][Full Text] [Related]
10. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?
Gerovassili A; Garner C; Nicolaides KH; Thein SL; Rees DC
Prenat Diagn; 2007 Feb; 27(2):104-10. PubMed ID: 17152117
[TBL] [Abstract][Full Text] [Related]
11. The effect of Rhesus status on first-trimester pregnancy screening markers free beta human chorionic gonadotropin, pregnancy-associated plasma protein-A and nuchal translucency.
Cowans NJ; Stamatopoulou A; Spencer K
Prenat Diagn; 2009 May; 29(5):505-7. PubMed ID: 19222026
[TBL] [Abstract][Full Text] [Related]
12. [Prenatal diagnostics in Arhus and Viborg Counties after implementation of first trimester risk assessment].
Tørring N; Jølving LR; Petersen OB; Holmskov A; Hertz JM; Uldbjerg N
Ugeskr Laeger; 2008 Jan; 170(1):50-4. PubMed ID: 18208717
[TBL] [Abstract][Full Text] [Related]
13. Fetal chromosomal abnormalities: antenatal screening and diagnosis.
Anderson CL; Brown CE
Am Fam Physician; 2009 Jan; 79(2):117-23. PubMed ID: 19178062
[TBL] [Abstract][Full Text] [Related]
14. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
Bronshtein M; Zimmer EZ; Blazer S
Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and prediction of parental origin of triploidies by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11-14 weeks of gestation.
Barken SS; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Brøndum-Nielsen K
Acta Obstet Gynecol Scand; 2008; 87(9):975-8. PubMed ID: 18720036
[TBL] [Abstract][Full Text] [Related]
16. Prenatal genetic screening and diagnosis for pediatricians.
Cunniff C; Hudgins L
Curr Opin Pediatr; 2010 Dec; 22(6):809-13. PubMed ID: 20829690
[TBL] [Abstract][Full Text] [Related]
17. Alternate methods of first-trimester diagnosis.
Viscarello RR; Gollin YG; Hobbins JC
Obstet Gynecol Clin North Am; 1991 Dec; 18(4):875-90. PubMed ID: 1803307
[TBL] [Abstract][Full Text] [Related]
18. Early first-trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins.
Linskens IH; Spreeuwenberg MD; Blankenstein MA; van Vugt JM
Prenat Diagn; 2009 Jan; 29(1):74-8. PubMed ID: 19173346
[TBL] [Abstract][Full Text] [Related]
19. [Three-dimensional scatter plot analysis to estimate the risk of foetal aneuloidy].
Schmidt P; Hörmansdörfer C; Oehler K; Härtel H; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2008 Aug; 212(4):127-35. PubMed ID: 18729035
[TBL] [Abstract][Full Text] [Related]
20. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
Bestwick JP; Huttly WJ; Wald NJ
J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]